ENFN

11.14

0.27% 0.03

Vorhandelsmarkt: 10.99 -0.15 -1.35%

Enfusion Inc (ENFN)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

$11.11

Offen:

$11.08

24-Stunden-Volumen:

496.48K

Relative Volume:

0.49

Marktkapitalisierung:

$1.05B

Einnahmen:

$174.54M

Nettoeinkommen (Verlust:

$6.03M

KGV:

139.25

EPS:

0.08

Netto-Cashflow:

$15.96M

1W Leistung:

-0.18%

1M Leistung:

-2.96%

6M Leistung:

+24.19%

1J Leistung:

+21.09%

1-Tages-Spanne:

$11.07

$11.17

1-Wochen-Bereich:

$11.03

$11.20

52-Wochen-Spanne:

$7.83

$11.80

Enfusion Inc Stock (ENFN) Company Profile

Firmenname

Enfusion Inc

Sektor

Technology (775)

Branche

Software - Application (268)

Telefon

(312) 253-9800

Adresse

125 SOUTH CLARK STREET, SUITE 750, CHICAGO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-08-06

Neueste SEC-Einreichungen

ENFN's Discussions on Twitter

Vergleichen Sie ENFN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ENFN Enfusion Inc	11.14	1.05B	174.54M	6.03M	15.96M	0.08
SAP Sap Se Adr	271.42	316.61B	36.97B	3.37B	4.79B	2.8498
CRM Salesforce Inc	271.54	259.66B	37.90B	6.20B	12.43B	6.36
INTU Intuit Inc	620.91	171.59B	17.17B	3.04B	5.63B	10.72
NOW Servicenow Inc	824.03	167.58B	10.98B	1.43B	3.38B	6.83
ADBE Adobe Inc	385.78	164.42B	22.04B	6.75B	9.19B	15.18

Enfusion Inc Stock (ENFN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-05-10	Fortgesetzt	Morgan Stanley	Overweight
2024-02-28	Herabstufung	Goldman	Neutral → Sell
2024-01-30	Herabstufung	JP Morgan	Neutral → Underweight
2023-11-07	Eingeleitet	UBS	Neutral
2023-04-03	Eingeleitet	Piper Sandler	Neutral
2023-03-15	Eingeleitet	JP Morgan	Neutral
2023-01-04	Herabstufung	BofA Securities	Neutral → Underperform
2023-01-03	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2022-10-03	Herabstufung	BofA Securities	Buy → Neutral
2021-11-15	Eingeleitet	BofA Securities	Buy
2021-11-15	Eingeleitet	Credit Suisse	Neutral
2021-11-15	Eingeleitet	Goldman	Neutral
2021-11-15	Eingeleitet	Morgan Stanley	Equal-Weight
2021-11-15	Eingeleitet	Piper Sandler	Overweight
2021-11-15	Eingeleitet	Stifel	Buy
2021-11-15	Eingeleitet	William Blair	Outperform

Alle ansehen

Enfusion Inc Aktie (ENFN) Neueste Nachrichten

Apr 02, 2025

Clearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger Consideration - 01net

Apr 02, 2025

Critical Merger Deadline: Enfusion Shareholders Must Choose Payment Type by April 16 - Stock Titan

Apr 02, 2025

ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc.ENFN - Business Wire

Apr 02, 2025

Mar 30, 2025

Learn to Evaluate (ENFN) using the Charts - news.stocktradersdaily.com

Mar 30, 2025

Mar 27, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Enfusion, Inc. (ENFN) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Mar 27, 2025

Mar 26, 2025

Lost Money on Enfusion, Inc. (ENFN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire

Mar 26, 2025

Mar 24, 2025

Bank of New York Mellon Corp Increases Stock Holdings in Enfusion, Inc. (NYSE:ENFN) - Defense World

Mar 24, 2025

Mar 20, 2025

Enfusion CEO Oleg Movchan sells $130,472 in stock By Investing.com - Investing.com South Africa

Mar 08, 2025

Rhumbline Advisers Has $643,000 Stake in Enfusion, Inc. (NYSE:ENFN) - Defense World

Mar 08, 2025

Enfusion’s chief people officer sells shares worth $35,558 - Investing.com India

Mar 08, 2025

Enfusion CFO sells $52,836 in stock to cover tax obligations By Investing.com - Investing.com Canada

Mar 08, 2025

Mar 07, 2025

Enfusion Executives Cash In: Major Stock Sales Unveiled! - TipRanks

Mar 07, 2025

Enfusion chief accounting officer sells $6,165 in stock By Investing.com - Investing.com Canada

Mar 07, 2025

Enfusion’s general counsel Matthew Campobasso sells $19,280 in stock - Investing.com

Mar 07, 2025

Enfusion chief accounting officer sells $6,165 in stock - Investing.com

Mar 07, 2025

Enfusion COO Neal Pawar sells $165,620 in stock - Investing.com

Mar 07, 2025

Enfusion’s chief people officer sells shares worth $35,558 By Investing.com - Investing.com South Africa

Mar 07, 2025

Enfusion Executives Sell Shares to Cover Tax Obligations - TradingView

Mar 07, 2025

Enfusion’s Hold Rating: Balancing Strategic Merger Benefits with Market Uncertainties - TipRanks

Mar 07, 2025

Enfusion CEO Oleg Movchan sells $130,472 in stock - Investing.com

Mar 07, 2025

Mar 06, 2025

Enfusion’s CAO Makes a Noteworthy Stock Sale! - TipRanks

Mar 06, 2025

Enfusion’s general counsel sells $12,410 in stock to cover taxes By Investing.com - Investing.com South Africa

Mar 06, 2025

Enfusion COO Neal Pawar sells $31,790 in stock - Investing.com India

Mar 06, 2025

Enfusion Executives Unload Major Stock Holdings! - TipRanks

Mar 06, 2025

Mar 05, 2025

Enfusion COO Neal Pawar sells $31,790 in stock By Investing.com - Investing.com Canada

Mar 05, 2025

Enfusion chief accounting officer sells $2,514 in stock - Investing.com Australia

Mar 05, 2025

Enfusion chief accounting officer sells $2,514 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025

Enfusion CEO Oleg Movchan sells $32,031 in stock By Investing.com - Investing.com Canada

Mar 05, 2025

Enfusion CFO Bradley Herring sells $17,600 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025

Enfusion’s chief people officer sells shares worth $23,696 - Investing.com India

Mar 05, 2025

Enfusion CEO Oleg Movchan sells $32,031 in stock - Investing.com

Mar 05, 2025

Enfusion’s chief people officer sells shares worth $23,696 By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 04, 2025

Stifel maintains Enfusion stock Hold rating, $11.25 target By Investing.com - Investing.com Canada

Mar 04, 2025

Stifel maintains Enfusion stock Hold rating, $11.25 target - Investing.com India

Mar 04, 2025